Women's Health News

RSS

Multi-center clinical trial of MyoSure Hysteroscopic Tissue Removal System initiated

Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.

30 Mar 2010

Breast cancer patients undertreated, essential radiation after mastectomy not performed

While radiation therapy is common after breast conserving surgery, it's much less frequent after mastectomy, even among women for whom it would have clear life-saving benefit. This is according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

30 Mar 2010

Few pregnant women meet physical activity guidelines set by health officials: Study

Fewer than 1 in 4 pregnant women meet physical activity guidelines set by doctors and health officials, according to a University of North Carolina at Chapel Hill study.

30 Mar 2010

Systemic treatment of microRNA therapeutic targeting miR-10b inhibits breast cancer metastasis

Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.

30 Mar 2010

CEO Roundtable on Cancer announces Gold Standard accreditation for Susan G. Komen for the Cure

Susan G. Komen for the Cure®, the world's largest breast cancer organization, has received CEO Cancer Gold Standard™ accreditation, recognizing the organization's commitment to reducing the risk of cancer for its employees and their families by promoting healthy lifestyle choices, by encouraging early detection through cancer screenings, and by ensuring access to quality treatment.

30 Mar 2010

In pregnant women, DVT more likely to occur on left side

Deep vein thrombosis (DVT) in pregnant patients is more likely to occur on the left side, and in particular in the left leg, write the authors of a Review article in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/embargo/cmaj091692.pdf.

30 Mar 2010

Obama's calm demeanor, Pelosi's firm stand helped push health care law

President Barack Obama and Democrats missed repeated deadlines, fought back cries of 'death panels' and watched healthcare reform nearly die more than dozen times. Through it all, Obama was the steady captain of the ship, his top aides say, a role the president has played since the early days of the 2008 presidential campaign.

30 Mar 2010

Gene expression in breast tissue may help explain pregnancy-associated breast cancer

Expression of inflammatory-related genes in breast tissue of women who have previously given birth may explain the aggressiveness and frequency of pregnancy-associated breast cancer, according to new research at the University of Illinois at Chicago.

30 Mar 2010

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that interim data from the first large-scale independent evaluation of clinical performance of Cervista® HPV HR compared to Hybrid Capture 2 (hc2), were presented at the 4th Biennial Meeting of AOGIN (Asia-Oceanic Research Organization in Genital Infection and Neoplasia) in New Delhi, India on March 26-28, 2010.

29 Mar 2010

Six weeks of radiotherapy to be consolidated into 30 minutes for breast cancer patients

Nearly 45 thousand women are diagnosed with breast cancer each year. Two third of these women need a combination of surgery and radiotherapy. Radiotherapy can kill cancer cells that may have been missed during operation. These remnant cells are responsible for 90% relapses.

29 Mar 2010

Federal funding of elective abortion: Obama signs executive order, FRC Action PAC comments

Today, President Obama signed an executive order regarding federal funding of elective abortion following passage of health care reform legislation.

27 Mar 2010

Cook Medical's new IVF culture-oil purification process reduces contaminant trace to below detectable limits

A new purification process developed by Cook Medical for culture oil used in assisted reproduction eliminates traces of contaminants below detectable limits of 0.1 parts per million. The oil is purified by a proprietary refining technique that removes hydrocarbon impurities, which can have adverse effects on fertilization and threaten the viability of the developing embryos. The culture oil viscosity, MEA and LAL parameters remain unchanged.

27 Mar 2010

Lymph node radiotherapy well-tolerated after mastectomy or breast conserving surgery

In patients with early breast cancer, giving radiotherapy to the lymph nodes located behind the breast bone and above the collar bone is well-tolerated, after mastectomy or breast conserving surgery, a radiation oncologist will tell delegates at the seventh European Breast Cancer Conference (EBCC7) today (Saturday 27 March).

27 Mar 2010

Radio ad supports legislation to end cash for egg donation

Today, Family Research Council Action and the Oklahoma Family Policy Council released a radio advertisement supporting State Representative Rebecca Hamilton's Oklahoma House Bill 3077, currently being reviewed by the Oklahoma State Senate. H.B. 3077 would put an end to the financial lure that draws young women into donating their eggs to fertility clinics, a dangerous procedure that can cause life-threatening complications including kidney failure and blood clots.

27 Mar 2010

Presence of PARP protein in tumours can help predict their response to chemotherapy

The presence of the protein poly polymerase in tumours can help predict their response to chemotherapy, a German scientist will tell the seventh European Breast Cancer Conference in Barcelona tomorrow (Saturday 27 March).

27 Mar 2010

Studies shed light on treatment options for women carrying BRCA1 and BRCA2 genetic mutations

Two studies to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday) and tomorrow (Saturday), shed light on the treatment options facing women carrying the BRCA1 and BRCA2 genetic mutations which predispose them to breast cancer.

27 Mar 2010

Genome sequencing of tumors biopsied from women with invasive breast cancer

Tumors biopsied from women with invasive breast cancer are having their genomes sequenced in an attempt to develop a DNA profile that one day may identify ahead of time the patients who will most likely respond to chemotherapy with an aromatase inhibitor. Aromatase inhibitors are a class of chemotherapeutic agents that block the production of estrogen in postmenopausal women.

27 Mar 2010

Ford Motor donates $255,000 to fund completion of Oakwood Healthcare System's research study

Ford Motor Company announced today it is donating an additional $255,000 to fund the completion of a pioneering multi-year Oakwood Healthcare System research study into the prevention of heart disease – a leading cause of death among American women.

27 Mar 2010

Survival improving in patients with HER2 positive metastatic breast cancer

Barcelona, Spain: Trends indicate that survival is improving in patients with metastatic breast cancer, especially in those patients whose tumours are described as being HER2 (human epidermal growth factor receptor-2) positive, a surgical oncologist will say today at the seventh European Breast Cancer Conference (EBCC7).

26 Mar 2010

Study finds 15-year outcomes of BCT and mastectomy similar

26 Mar 2010

Women's Health News

Multi-center clinical trial of MyoSure Hysteroscopic Tissue Removal System initiated

Breast cancer patients undertreated, essential radiation after mastectomy not performed

Few pregnant women meet physical activity guidelines set by health officials: Study

Systemic treatment of microRNA therapeutic targeting miR-10b inhibits breast cancer metastasis

CEO Roundtable on Cancer announces Gold Standard accreditation for Susan G. Komen for the Cure

In pregnant women, DVT more likely to occur on left side

Obama's calm demeanor, Pelosi's firm stand helped push health care law

Gene expression in breast tissue may help explain pregnancy-associated breast cancer

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Six weeks of radiotherapy to be consolidated into 30 minutes for breast cancer patients

Federal funding of elective abortion: Obama signs executive order, FRC Action PAC comments

Cook Medical's new IVF culture-oil purification process reduces contaminant trace to below detectable limits

Lymph node radiotherapy well-tolerated after mastectomy or breast conserving surgery

Radio ad supports legislation to end cash for egg donation

Presence of PARP protein in tumours can help predict their response to chemotherapy

Studies shed light on treatment options for women carrying BRCA1 and BRCA2 genetic mutations

Genome sequencing of tumors biopsied from women with invasive breast cancer

Ford Motor donates $255,000 to fund completion of Oakwood Healthcare System's research study

Survival improving in patients with HER2 positive metastatic breast cancer

Study finds 15-year outcomes of BCT and mastectomy similar

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News